Is Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) a Buy, Sell, or Hold?
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
$10.67 USD
$0 (0.0%)
- Volume
- 48.74K
- Average Volume
- 111.47K
- Market Capitalization
- $359.76M
- P/E Ratio
- 52.15
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $10.68
- Year Low
- $10.21
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.03
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Roger Bendelac |
| Industry | Shell Companies |
| Sector | Financial Services |
| Current Symbol | DMAA |
| CUSIP | G2847J104 |
| CIK | 0002028614 |
| Web | https://dmaacorp.com |
| Phone | (954) 870-3099 |
| Currency | USD |
| Employees | 2 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Cash Ratio | 0.03 |
Sales & Book Value
| Annual Sales | $- |
| Price / Sales | 0.00 |
| Cash Flow | -0.02 |
| Price / Cash Flow | -948.76 |
| Price / Book | 1.05 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Neutral |
| Rating Score(0-5) | 3 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $0.19 |
| Trailing P/E Ratio | 52.15 |
| PEG Ratio | -0.52 |
| P/E Growth | -0.52 |
| Net Income | $5.94M |
| Net Margin | 0.00% |
| Pretax Margin | 0.00% |
| Return on Equity | 2.88% |
| Return on Assets | 2.75% |
Financials Score
| AltmanZ Score | 29.15 |
| Piotroski Score | 2.00 |
| Working Capital | -477.28K |
| Total Assets | 242.04M |
| Ebit | -2.63M |
| Market Cap | 360.1M |
| Total Liabilities | 7.39M |
Poll Results
About Drugs Made In America Acquisition Corp. Ordinary Shares (NASDAQ:DMAA) Stock
Drugs Made In America Acquisition Corp. functions as a special purpose acquisition company, commonly known as a blank check company. Its core mission is to seek out and ultimately acquire one or more existing businesses or their assets. This acquisition strategy encompasses a variety of transactional methods, such as corporate mergers, capital stock exchanges, direct asset purchases, stock acquisitions, or broader corporate reorganizations. ...
Frequently Asked Questions
-
What is the current Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) stock price?
-
Drugs Made In America Acquisition Corp. Ordinary Shares(NASDAQ:DMAA) stock price is $10.67 in the last trading session. During the trading session, DMAA stock reached the peak price of $10.68 while $10.21 was the lowest point it dropped to. The percentage change in DMAA stock occurred in the recent session was 0.0% while the dollar amount for the price change in DMAA stock was $0.
-
DMAA's industry and sector of operation?
-
The NASDAQ listed DMAA is part of Shell Companies industry that operates in the broader Financial Services sector.
-
Who are the executives of DMAA?
-
Roger Bendelac | Chief Executive Officer
Saleem Elmasri | CFO & Principal Accounting Officer
|
|
| -
How many employees does DMAA have?
-
Number of DMAA employees currently stands at 2. DMAA operates from 1 East Broward Blvd Suite 700, Fort Lauderdale, FL 33301, US.
-
Link for DMAA official website?
-
Official Website of DMAA is: https://dmaacorp.com
-
How do I contact DMAA?
-
DMAA could be contacted at phone #(954) 870-3099 and can also be accessed through its website. DMAA operates from 1 East Broward Blvd Suite 700, Fort Lauderdale, FL 33301, US.
-
How many shares of DMAA are traded daily?
-
The average number of DMAA shares traded daily for last 3 months was 111.47K.
-
What is the market cap of DMAA currently?
-
The market value of DMAA currently stands at $359.76M with its latest stock price at $10.67